NCT03662828|Unknown
Epidemiological Description of the Kaposi's Disease in France's Southeast
KAPOSI-1
Loading search results
KAPOSI-1
Sponsor study identifier
observational
100
1 country
5
Study Start
August 1, 2018
Actual (reported)Primary Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 23, 2018
Actual (reported)August 1, 2018
Actual (reported)September 10, 2018
Actual (reported)August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Prevalence of Kaposi's disease
Diagnosed patients with biopsy, in France's southeast
10 years (2007-2017)
Descriptive analysis of the different form of the Kaposi's disease in the population
10 years (2007-2017)
Descriptive analysis of the population : sociodemographic
10 years (2007-2017)
Descriptive analysis of the population : paraclinical
10 years (2007-2017)
Descriptive analysis of the population : clinical
10 years (2007-2017)
Descriptive analysis of the population : therapeutic
10 years (2007-2017)
Diagnosed patients with a Kaposi's disease by biopsy from January 2007 to December 2017
Centre Antoine Lacassagne
Nice, Alpes-Maritimes, 06000, France
CHU Nice
Nice, Alpes-Maritimes, 06000, France
HIA Laveran
Marseille, Bouche Du Rhone, 13384, France
CHI de Fréjus
Fréjus, Var, 83600, France
Hôpital d'Instruction des Armées Sainte-Anne
Toulon, Var, 83000, France
First Submitted
July 23, 2018
First Posted
September 10, 2018
Study Start
August 1, 2018
Actual (reported)Primary Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Contact the study team to confirm eligibility.
Study Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 14, 2019
Record last verified: 2019-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: